Target intelligence / Profile preview

Subcutaneous tissue extracellular matrix (ECM)

Target
ECM
Molecular classification
Other (complex tissue matrix, not a molecule), Collagen family, proteoglycan family, glycoproteins, elastin family
01

Overview

The subcutaneous tissue extracellular matrix is a heterogeneous, three-dimensional meshwork of proteins, glycoproteins, and polysaccharides surrounding cells of the subcutaneous tissue. It maintains tissue structure and enables transmission of biochemical and biomechanical signals. Its composition includes collagens (mainly types I and III in soft connective tissue), elastin for elasticity, fibronectin and laminin for cell adhesion, and various proteoglycans for hydration and resilience. It regulates migration, proliferation, and differentiation of embedded cells, mediates wound healing and tissue repair, and plays critical roles in many disease processes when its balance is disrupted. This entity should *not* be considered a canonical molecule or receptor target for drug discovery or molecular targeting; instead, focus on its individual protein components or matrix-modifying enzymes for pharmacological intervention.

Other names
Extracellular matrix (ECM)connective tissue matrixsubcutaneous connective tissue ECM
02

Mechanism of action

MMP inhibitors: Block breakdown of ECM during pathological remodeling; Integrin antagonists: Inhibit cell-matrix interactions; Collagenase: Enzymatically degrade collagen for therapeutic purposes

03

Biological functions

Structural supportCell adhesionRegulation of cell migration, proliferation, and differentiationSignal transduction (by interacting with cell surface receptors)Wound healing and tissue regenerationBarrier function
04

Disease associations

FibrosisInflammationCancer (invasion, metastasis)Infection (barrier function)Tissue injuryLipodystrophy (adipose tissue disorder)Other
05

Safety considerations

ECM therapies and interventions may induce immune responsesabnormal fibrosis (scarring)impaired regenerationunintended tissue remodelinglocal inflammation
06

Interacting drugs

None
07

Biomarkers

Collagen fragmentsMMPsfibronectinlamininhyaluronan

Beyond the preview

Go deeper on Subcutaneous tissue extracellular matrix (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Subcutaneous tissue extracellular matrix (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call